Mundipharma expands opioid antidote push abroad
Mundipharma, linked to the Sackler family, broadens a strategy to dominate naloxone sales outside the United States with Nyxoid nasal spray. Critics label the move cynical as Purdue trials reveal “Project Tango” aimed to sell addiction treatment alongside opioids. Australia, Europe, and New Zealand have seen regulatory steps and subsidies boosting access to Nyxoid amid debates over pricing and corporate influence.
MENTIONED IN THIS ARTICLE
Purdue Pharma
United States
Mundipharma
Sackler
Europe
Australia
Ross Bell
The
New Zealand Drug Foundation
New Zealand
Patrice Grand
Mundipharma Europe
U.S
Narcan
Nyxord
Grand
Purdue
Massachusetts
New York
Kathe Sackler
Project Tango
Sacklers
New South Wales
Nyxoid
Brian Muller
Harriet Grahame
Drug Policy Institute
Greg
Hunt
Mundipharma Australia
Norway
Thomas Clausen
University of Oslo
Clausen
Also Mentioned on This Page
Wein
AP Leila Coker
Mundipharma International
Cambridge Science Park
England
Taos
Peg Ty
West Tosc. St
Canton
Massiton Crit Center
Lincoln Way
Massitton
Ag Cea Ce
Plumbing, LLC
Weeteslys
Red Tomato
Mt. Eaton Merchants
Deli
Smith
Walnut Creek
Rebecca
East Main St
Mt. Eaton
RedTomatoMarketFoods.com